The Seven-Valent Pneumococcal Conjugate Vaccine Reduces Tympanostomy Tube Placement in Children
- 1 August 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 23 (8), 732-738
- https://doi.org/10.1097/01.inf.0000133049.30299.5d
Abstract
The novel pneumococcal conjugate vaccine, PncCRM, has been shown to prevent acute otitis media caused by vaccine serotypes and to reduce otitis surgery. Our aim was to assess long term efficacy of the vaccine on tympanostomy tube placements. Children with complete follow-up in the Finnish Otitis Media Vaccine Trial up to 24 months of age and still living in the study area (1490 of 1662 randomized at 2 months of age) were invited to a single visit at 4–5 years of age. The children had been vaccinated at 2, 4, 6 and 12 months of age with PncCRM or hepatitis B vaccine (control). Tympanostomy tube placements reported by parents at the visit were verified from hospital and private medical center records. Additionally, tympanostomy tube placements of all children were verified from the hospital discharge registry. Vaccine efficacy (VE) was estimated by comparing all events of tympanostomy tube placement between vaccine groups. During the vaccine trial (2–24 months of age), VE (95% confidence interval) in preventing tympanostomy tube placement was only 4% (– 19–23%). Altogether 756 children were enrolled for the follow-up study. After 24 months of age, the rate of surgery was 3.5 per 100 person-years in the PncCRM and 5.7 per 100 person-years in the control children, giving VE of 39% (4–61%). In the hospital-based data of all children (N = 1490), VE of 44% was obtained (19–62%). Receipt of PncCRM vaccine at infancy was associated with a reduction in tympanostomy tube placement from 2 to 4–5 years of age.Keywords
This publication has 17 references indexed in Scilit:
- Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised studyThe Lancet, 2003
- Physician and Population Determinants of Rates of Middle-Ear Surgery in OntarioJAMA, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Antibiotic Use by Indication: A Basis for Active Antibiotic Policy in the CommunityScandinavian Journal of Infectious Diseases, 2001
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Antibiotic Prescribing for Canadian Preschool Children: Evidence of Overprescribing for Viral Respiratory InfectionsClinical Infectious Diseases, 1999
- Management of otitis media among children in a large health insurance planThe Pediatric Infectious Disease Journal, 1999
- Otitis Media in 2253 Pittsburgh-Area Infants: Prevalence and Risk Factors During the First Two Years of LifePublished by American Academy of Pediatrics (AAP) ,1997
- Effects of frailty in survival analysisStatistical Methods in Medical Research, 1994
- Otitis Media in Infancy and Intellectual Ability, School Achievement, Speech, and Language at Age 7 YearsThe Journal of Infectious Diseases, 1990